Close Menu

NEW YORK – Qiagen said after the close of the market on Monday that it is collaborating with Amgen to develop tissue-based companion diagnostics for Amgen's investigational treatment AMG 510 for non-small cell lung cancer (NSCLC).

The Therascreen CDx test will use real-time PCR to identify patients with cancers that have the KRAS G12C mutation, one of the most common causes of cancer. The RAS gene family includes the most frequently mutated oncogenes in cancers with KRAS being the most prevalent driver in NSCLC.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A federal judge has ruled that drug companies, device manufacturers, and universities need to provide missing clinical data from hundreds of trials to a federal website, ScienceInsider reports.

NPR reports that the US Centers for Disease Control and Prevention has fixed the problem with some of its SARS-CoV-2 testing kits.

A genetic analysis suggests red pandas might actually belong to two different species, New Scientist reports.

In Nature this week: epigenetic factors that prevent healthy aging and more.

Mar
18
Sponsored by
Roche

This webinar will discuss data from a recent real-world comparison study evaluating performance of two cell-free DNA methodologies as first-line prenatal screens.

Mar
31
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.